Skip to main content
UniHealth

Doctor search

Lenito M Navarro, PA

Physician Assistant · Stanford

NPI 1508039199

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lenito M Navarro’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$10,152

Medicare paid this office $10,152 for 74 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)38$5,614$106
Biopsy and aspiration of bone marrow sample for diagnosis28$1,695$57

Who their Medicare patients are

74 Original Medicare patients in 2024. Average age 68 · Under 65 15% · 85 and older 0% · Women 49% · Also on Medicaid 27% · Health risk score 2.81. Sicker patients than 9 in 10 peers; the typical physician assistant clinician is at 1.31.

Conditions among them: High blood pressure 62% · Chronic kidney disease 30% · Diabetes 23% · Coronary heart disease 22% · Depression 18% · Atrial fibrillation 16% · Cancer 15%.

The office billed $56,292, Medicare allowed $13,175 and paid $10,152; for 116 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202474116682.81$56,292$10,152
202377136673.11$51,396$13,219
202265119662.85$40,697$11,209
202168110673.07$30,789$11,149
202074188673.30$90,358$14,948
201968129663.56$91,346$9,745
20185289653.51$75,536$6,827
201788158722.48$176,380$7,429
201653106672.19$206,862$4,113
201574160722.21$253,377$5,272
20144778673.19$47,795$4,332
20132747663.17$24,718$2,077

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)55$9,815$112
Biopsy and aspiration of bone marrow sample for diagnosis23$1,488$60

2022: 4 services

Original Medicare services billed in 2022
Long return visit (40+ min)45$7,388$110
Return visit (30+ min)17$1,465$73
Removal of tunneled central venous tube12$1,299$108
Biopsy and aspiration of bone marrow sample for diagnosis14$963$60

2021: 2 services

Original Medicare services billed in 2021
Long return visit (40+ min)42$8,152$118
Biopsy and aspiration of bone marrow sample for diagnosis15$1,051$62

2020: 3 services

Original Medicare services billed in 2020
Long return visit (40+ min)57$10,730$86
Biopsy and aspiration of bone marrow sample for diagnosis20$1,363$59
Return visit (30+ min)12$813$63

2019: 2 services

Original Medicare services billed in 2019
Long return visit (40+ min)46$6,929$82
Return visit (30+ min)19$1,464$61

2018: 3 services

Original Medicare services billed in 2018
Long return visit (40+ min)32$4,494$85
Biopsy and aspiration of bone marrow sample for diagnosis12$764$59
Return visit (30+ min)11$660$60

2017: 4 services

Original Medicare services billed in 2017
Biopsy of bone marrow44$2,662$55
Long return visit (40+ min)20$2,202$85
Return visit (30+ min)26$1,739$58
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service40$287$7

2016: 2 services

Original Medicare services billed in 2016
Biopsy of bone marrow39$2,345$57
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service35$239$7

2015: 2 services

Original Medicare services billed in 2015
Biopsy of bone marrow65$4,141$55
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service62$471$7

2014: 3 services

Original Medicare services billed in 2014
Biopsy of bone marrow19$1,175$59
Long return visit (40+ min)12$1,006$84
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service16$116$7

2013: 2 services

Original Medicare services billed in 2013
Biopsy of bone marrow16$843$50
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service13$77$6

Drugs they prescribed that Part D paid

$42,313

Pharmacies billed $42,313 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

172 generic and fewer than 11 brand-name prescriptions · $42,313 in drug cost · 45 antibiotic prescriptions to 25 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Acyclovir32$455$14
Sulfamethoxazole-Trimethoprim39$211$5

Year by year

Part D prescribing by year
202418272NoneNone$42,313
202321363NoneNone$153,618
202210747NoneNone$12,910
202115761NoneNone$79,379
2020201629% (17)None$100,082
201914961None8%$54,767
2018177649% (15)20%$130,158
20172359112% (29)32%$385,724
20162508818% (44)36%$430,843
20151395821% (29)22%$109,947
20141104311% (12)15%$25,890
201312239NoneNone$60,462

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Eliquis12$11,796$983
Acyclovir29$689$24
Sulfamethoxazole-Trimethoprim42$348$8

2022: 1 drug

Part D drugs prescribed in 2022
Sulfamethoxazole-Trimethoprim30$250$8

2021: 2 drugs

Part D drugs prescribed in 2021
Acyclovir26$1,195$46
Sulfamethoxazole-Trimethoprim11$95$9

2020: 3 drugs

Part D drugs prescribed in 2020
Tacrolimus18$1,609$89
Acyclovir22$551$25
Lorazepam12$85$7

2019: 2 drugs

Part D drugs prescribed in 2019
Atovaquone11$9,108$828
Sulfamethoxazole-Trimethoprim30$188$6

2018: 3 drugs

Part D drugs prescribed in 2018
Noxafil14$80,322$5,737
Atovaquone12$8,007$667
Sulfamethoxazole-Trimethoprim13$124$10

2017: 4 drugs

Part D drugs prescribed in 2017
Imbruvica16$176,184$11,011
Hydroxyurea12$518$43
Valacyclovir13$335$26
Acyclovir12$273$23

2016: 4 drugs

Part D drugs prescribed in 2016
Imbruvica17$174,132$10,243
Hydrocodone-Acetaminophen16$486$30
Acyclovir17$240$14
Dexamethasone14$119$8

2013: 1 drug

Part D drugs prescribed in 2013
Humalog11$3,161$287

Money from drug and device companies

$1,048 in 2025

Industry payments by year
20251332None$1,048
20241322None$610
2023923None$591
202248None$186
202133None$127

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Janssen BiotechRybrevant$213
4 payments
  • Meals for Talvey · 2025-11-10 · $39
  • Meals for Talvey · 2025-10-06 · $26
  • Meals for Darzalex · 2025-05-29 · $16
  • Meals for Rybrevant · 2025-05-12 · $132
Syndax PharmaceuticalsRevuforj$147
1 payment
  • Meals for Revuforj · 2025-05-13 · $147
Merck Sharp & DohmeKeytruda$116
4 payments
  • Meals for Keytruda · 2025-10-14 · $27
  • Meals for Keytruda · 2025-07-25 · $31
  • Meals for Keytruda · 2025-07-08 · $30
  • Meals for Welireg · 2025-01-31 · $28
AstraZeneca Pharmaceuticals LPCalquence$115
5 payments
  • Meals for Calquence · 2025-12-22 · $26
  • Meals for Calquence · 2025-10-07 · $25
  • Meals for Calquence · 2025-07-18 · $26
  • Meals for Calquence · 2025-04-25 · $15
  • Meals for Calquence · 2025-01-01 · $22
CelgeneBreyanzi$93
4 payments
  • Meals for Reblozyl · 2025-10-07 · $18
  • Meals for Breyanzi · 2025-07-29 · $30
  • Meals for Breyanzi · 2025-07-08 · $29
  • Meals for Opdivo · 2025-04-22 · $16
BeOne Medicines USABrukinsa$90
3 payments
  • Meals for Brukinsa · 2025-11-04 · $29
  • Meals for Brukinsa · 2025-09-29 · $29
  • Meals for Brukinsa · 2025-06-16 · $31
See all 32 published payments
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-22Calquence$26
Stemline TherapeuticsMeals · 2025-11-29Elzonris$29
Janssen BiotechMeals · 2025-11-10Talvey$39
BeOne Medicines USAMeals · 2025-11-04Brukinsa$29
PharmaEssentia USAMeals · 2025-10-27Besremi$19
Merck Sharp & DohmeMeals · 2025-10-14Keytruda$27
CelgeneMeals · 2025-10-07Reblozyl$18
AstraZeneca Pharmaceuticals LPMeals · 2025-10-07Calquence$25
Janssen BiotechMeals · 2025-10-06Talvey$26
BeOne Medicines USAMeals · 2025-09-29Brukinsa$29
Rigel PharmaceuticalsMeals · 2025-09-22Tavalisse$30
Regeneron Healthcare SolutionsMeals · 2025-09-05Lynozyfic$25
CelgeneMeals · 2025-07-29Breyanzi$30
Regeneron Healthcare SolutionsMeals · 2025-07-28Lynozyfic$24
Merck Sharp & DohmeMeals · 2025-07-25Keytruda$31
Regeneron Healthcare SolutionsMeals · 2025-07-21Lynozyfic$24
AstraZeneca Pharmaceuticals LPMeals · 2025-07-18Calquence$26
AbbvieMeals · 2025-07-15Imbruvica$24
CelgeneMeals · 2025-07-08Breyanzi$29
Merck Sharp & DohmeMeals · 2025-07-08Keytruda$30
PharmaEssentia USAMeals · 2025-06-24Besremi$19
BeOne Medicines USAMeals · 2025-06-16Brukinsa$31
Janssen BiotechMeals · 2025-05-29Darzalex$16
Syndax PharmaceuticalsMeals · 2025-05-13Revuforj$147
Janssen BiotechMeals · 2025-05-12Rybrevant$132
AstraZeneca Pharmaceuticals LPMeals · 2025-04-25Calquence$15
CelgeneMeals · 2025-04-22Opdivo$16
AbbvieMeals · 2025-03-25Epkinly$30
Kite PharmaMeals · 2025-03-20Yescarta$28
Astellas Pharma USMeals · 2025-03-04Cresemba$23
Merck Sharp & DohmeMeals · 2025-01-31Welireg$28
AstraZeneca Pharmaceuticals LPMeals · 2025-01-01Calquence$22
See earlier years (2024, 2023, 2022, 2021)

2024: $610

Payments by company in 2024
AbbvieVenclexta$161
4 payments
  • Meals for Venclexta · 2024-11-19 · $125
  • Meals for Imbruvica · 2024-05-09 · $29
  • Meals for Imbruvica · 2024-05-09 · $6
  • Meals for Imbruvica · 2024-05-09 · $2
AstraZeneca Pharmaceuticals LPCalquence$81
3 payments
  • Meals for Calquence · 2024-11-25 · $28
  • Meals for Calquence · 2024-09-24 · $31
  • Meals for Calquence · 2024-04-16 · $22
Rigel PharmaceuticalsRezlidhia$78
4 payments
  • Meals for Rezlidhia · 2024-06-26 · $21
  • Meals for Rezlidhia · 2024-03-05 · $29
  • Meals for Rezlidhia · 2024-01-23 · $26
  • Meals for Rezlidhia · 2024-01-23 · $2
Janssen BiotechDarzalex$60
2 payments
  • Meals for Darzalex · 2024-12-16 · $23
  • Meals for Darzalex · 2024-08-27 · $36
Legend Biotech USANone$35
1 payment
  • Meals · 2024-05-07 · $35
Merck Sharp & DohmeKeytruda$31
1 payment
  • Meals for Keytruda · 2024-10-25 · $31
Lilly USAVerzenio$30
1 payment
  • Meals for Verzenio · 2024-09-18 · $30
IncytePemazyre$24
1 payment
  • Meals for Pemazyre · 2024-10-08 · $24
Servier PharmaceuticalsTibsovo$24
1 payment
  • Meals for Tibsovo · 2024-05-28 · $24
Kite PharmaYescarta$24
1 payment
  • Meals for Yescarta · 2024-08-26 · $24
Adaptive BiotechnologiesClonoseq$23
1 payment
  • Meals for Clonoseq · 2024-12-03 · $23
PharmaEssentia USABesremi$21
1 payment
  • Meals for Besremi · 2024-12-17 · $21
Daiichi SankyoVanflyta$17
1 payment
  • Meals for Vanflyta · 2024-10-01 · $17

2023: $591

Payments by company in 2023
Janssen BiotechImbruvica$158
6 payments
  • Meals for Darzalex · 2023-12-04 · $33
  • Meals for Imbruvica · 2023-08-22 · $27
  • Meals for Darzalex · 2023-05-31 · $27
  • Meals for Imbruvica · 2023-04-18 · $30
  • Meals for Imbruvica · 2023-04-17 · $8
  • Meals for Carvykti · 2023-03-06 · $33
Rigel PharmaceuticalsRezlidhia$84
5 payments
  • Meals for Rezlidhia · 2023-11-07 · $25
  • Meals for Rezlidhia · 2023-10-31 · $23
  • Meals for Rezlidhia · 2023-10-31 · $3
  • Meals for Rezlidhia · 2023-09-05 · $30
  • Meals for Rezlidhia · 2023-09-05 · $5
AstraZeneca Pharmaceuticals LPCalquence$84
2 payments
  • Meals for Calquence · 2023-10-24 · $29
  • Meals for Calquence · 2023-05-23 · $55
AmgenNplate$75
3 payments
  • Meals for Nplate · 2023-08-14 · $31
  • Meals for Nplate · 2023-06-20 · $28
  • Meals for Nplate · 2023-05-11 · $16
Pharmacyclics LLC An AbbVieImbruvica$71
2 payments
  • Meals for Imbruvica · 2023-03-08 · $41
  • Meals for Imbruvica · 2023-01-07 · $30
Kite PharmaYescarta$50
2 payments
  • Meals for Yescarta · 2023-11-28 · $23
  • Meals for Yescarta · 2023-10-03 · $26
CTI BioPharmaVonjo$28
1 payment
  • Meals for Vonjo · 2023-04-25 · $28
IncyteJakafi$21
1 payment
  • Meals for Jakafi · 2023-05-10 · $21
GlaxoSmithKlineOjjaara$20
1 payment
  • Meals for Ojjaara · 2023-11-13 · $20

2022: $186

Payments by company in 2022
Janssen BiotechCarvykti$89
4 payments
  • Meals for Imbruvica · 2022-12-19 · $24
  • Meals for Carvykti · 2022-10-26 · $24
  • Meals for Darzalex · 2022-07-27 · $21
  • Meals for Carvykti · 2022-07-19 · $20
AmgenKyprolis$52
2 payments
  • Meals for Nplate · 2022-10-24 · $25
  • Meals for Kyprolis · 2022-09-12 · $27
Pharmacyclics LLC an AbbVieImbruvica$24
1 payment
  • Meals for Imbruvica · 2022-07-25 · $24
IncyteMonjuvi$21
1 payment
  • Meals for Monjuvi · 2022-06-17 · $21

2021: $127

Payments by company in 2021
Sanofi-Aventis U.S.Elitek$99
1 payment
  • Education for Elitek · 2021-08-31 · $99
Janssen BiotechDarzalex$16
1 payment
  • Meals for Darzalex · 2021-12-20 · $16
GenzymeElitek$12
1 payment
  • Meals for Elitek · 2021-08-30 · $12

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1508039199
Licence
CA PA15483
Trained
University of Washington School of Medicine, 2000
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2008-04-04
NPI last updated
2025-12-18
NPI record certified
2025-12-18

This is when the NPI record was last certified, not a medical board exam.